Description:

GOG-0262: Biomarker Reporting Form (Form BMR) Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E5EDF6F-88D2-E23E-E040-BB89AD435A10

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E5EDF6F-88D2-E23E-E040-BB89AD435A10

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT01167712 On-Study - GOG-0262: Biomarker Reporting Form (Form BMR) - 2917747v1.0

No Instruction available.

  1. StudyEvent: GOG-0262: Biomarker Reporting Form (Form BMR)
    1. No Instruction available.
Header Module
Biomarker Information
Were biomarkers assessed during this reporting period
Comments

Similar models